Background: Aortic dissection (AD) is the most common aortic catastrophe. Carotid artery dissection due to extension of AD (CAEAD) is one severe complication of this condition. Despite years of refinement in the techniques for repair of AD, the optimal management strategy for CAEAD remains yet to be described. We hypothesized that CAEAD eventually resolves on antiplatelet therapy with a low but not insignificant risk of cerebrovascular accident (CVA).
Aortic dissections (AD) are the most common aortic catastrophe. Carotid artery extension of aortic dissection (CAEAD) is a potentially severe although relatively rare complication of AD. In fact, one of the most common causes of carotid artery dissection cited is AD. 1 Stroke, defined as a transient ischemic attack (TIA) or cerebrovascular accident (CVA), is seen in 6% to 16% of patients presenting with type A AD. [2] [3] [4] Isolated cervical carotid and vertebral artery dissections carry a <5% risk of stroke on medical management alone. 5 Despite a robust body of literature detailing the technical aspects of AD repair, the ideal management of CAEAD, whether surgical or medical therapy, is not well delineated. Historically, data on CAEAD has been scarce, and most guidelines are derived from expert opinion based on case reports and single-institution series. This is likely due to the often asymptomatic nature of this condition and previously limited sophistication of imaging techniques. Prior studies have also lacked long-term follow-up specifically addressing late sequelae. Modern imaging, including high-definition computed tomography (CT) angiography and the more prevalent use of duplex ultrasound imaging, has improved the recognition and diagnosis of CAEAD.
Classically, early revascularization of CAEAD was advocated by multiple international case reports. [6] [7] [8] [9] This was because of concern for recurrent CVA after the initial presentation, likely due to a belief that mural thrombus would result in carotid stenosis or distal thromboembolism. However, a recently published study advocated a strategy of aortic repair, followed by delayed carotid artery revascularization. The authors advocated that carotid repair was indicated only for recurrent symptoms attributable to CAEAD. 9 We hypothesize that CAEAD can be safely managed with antiplatelet therapy with a low risk of late CVA.
METHODS
This was a single institution analysis of a retrospectively collected database at an urban tertiary referral center. All data accrual was conducted under the University of Maryland Institutional Review Board protocol #HP-00049876, which waived consent. The database was developed by medical record abstraction for patients identified in administrative and billing data. The database included all patients diagnosed with any aortic pathology from 2001 to 2013. Patients were identified based on International Classification of Diseases, Ninth Revision, codes for thoracic aortic (441.01), thoracoabdominal aortic (441.03), and carotid artery (443.21) dissections. Cases of coincident aortic and carotid dissection were identified for review of electronic medical records, including all imaging reports, all CT scans, operative reports, and hospital dictations, to collect demographic, perioperative, and follow-up data. Patients were included if they had an initial contrasted CT study or clear documentation of the lesion at the time of operation by the attending surgeon to ensure accurate diagnosis of CAEAD. We excluded traumatic aortic and carotid injuries. Data concerning cerebrovascular ischemic events were obtained from clinic notes and imaging reports.
For the purpose of comparison, we identified four patient groups of interest: patients who did and did not survive the index admission, patients who survived and had interval CT follow-up (CTF) of their carotid lesions, and patients lost to CTF (LCTF) of their carotid lesions. Postdischarge mortality data were collected from commercially available databases that provided Social Security Death Index data through 2014 and allowed searching for published obituaries for patients not listed in the Social Security Death Index.
The Fisher exact test and Student t-test were used to compare groups where appropriate, with a P value of <.05 accepted as significant. Kaplan-Meier survival curves were generated for overall survival and survival in patients with and without CVA. The log-rank test was used to evaluate the significance of differences between survival curves.
RESULTS
We queried records for 3160 patients and found relevant diagnoses present in 453 patients, including 358 patients with thoracic AD and 95 with thoracoabdominal AD. CAED was identified by CT in 38 of these patients (8.4%).
The CAEAD group was 63% male (n ¼ 24), 66% Caucasian (n ¼ 25), 32% African American (n ¼ 12), and was a median age of 59.5 years (range, 25-85 years Differences between the demographics and comorbidity profiles of survivors and nonsurvivors of the index admission were not significant. Complete demographics are reported in Table I .
Patient and lesion characteristics are outlined in Table II . In short, 36 (95%) of the included patients were diagnosed with a Stanford type A dissection as the primary pathology. Two patients had Stanford type B lesions with retrograde extension of the dissection that involved their left common carotid arteries. The respective attending surgeons at the time determined that the patients' primary disease involved the descending aorta and that the proximal extension into the base of the left common carotid artery did not constitute involvement of the ascending arch and so the patients were managed as type B ADs. There were 17 patients (44.7%) with left common carotid artery dissections, 9 (23.7%) with right, and 12 patients (31.6%) with bilateral involvement. The differences between subgroups were not significant. Most patients, 32 of 38 (84%), arrived as transfers from other medical facilities. The most common presenting symptoms were chest, back, or neck pain, seen in 27 patients (71%), lower extremity malperfusion (10 [26%]), and stroke (7 [18%] ). The analyzed subgroups were not significantly different (Table II) .
Management strategies are reported in Table III , and relative distribution is seen in Fig 1. Of the 38 patients with CAEAD, 26 (68%) underwent open aortic repair, and four (11%) had endovascular management. Nonoperative management of AD in the setting of a diagnosis of CAEAD was pursued in nine patients (24%). In only eight patients (21%) undergoing open repair was great vessel replacement or bypass performed. One patient, with bilateral CAEAD, had a later right-sided carotid stenting procedure for >95% stenosis on interval imaging. The endovascular procedures included two endovascular fenestrations (5%) with branch vessel stenting, and thoracic endovascular aortic repairs in two patients (5%). One of these aortic stenting procedures was performed as part of a staged frozen elephant trunk hybrid procedure. We found no significant difference in treatment patterns between survivors and nonsurvivors. There were, however, some notable differences in the distributions of interventions, with relatively more nonoperative management (63% vs 47%) and less open repair (38% vs 86%) in the LCTF group compared with the CTF group (Table III; Fig 1) .
Nonoperative management was pursued for a variety of reasons. This was most often (5 [55%]) because of prior aortic intervention, including three patients with chronic type A dissections (2 after repair >5 years earlier at another center). These three patients had newly diagnosed extension into the carotids that was found incidentally during evaluation for other conditions. The other two patients had recent repair of ascending AD at other centers and presented with new-onset of severe chest pain that was associated only with new carotid artery extension. One was managed medically, and the other patient left against medical advice during evaluation. Strokes were evident in three of the nonoperatively managed patients at admission (all of these associated Atrial fibrillation 4 (11) 3 (10) 1 (13) 1 2 (9) 1 (13) .
Tobacco use 18 (47) 15 (50) 3 (38) .70 13 (59) 2 (25) . with the CAEAD lesion), the course of two of these are described below. The third patient with a TIA did well but was lost to follow-up after discharge and eventually died >4 years after discharge.
Three of the nine patients managed nonoperatively did not have attempts at aortic repair because of expected death. Two of these patients had significant neurologic injury that resulted in death. One had a large CVA and Half of the patients in the LCTF group were also managed nonoperatively at our facility. TEVAR, Thoracic endovascular aortic repair.
died of hemorrhagic conversion, the other had a massive CVA with poor prognosis for neurologic recovery. The families of both patients elected to withdraw care without attempting aortic or carotid repair. The third patient arrived at our medical center in cardiac arrest after transport and could not be stabilized for operative intervention. These were the only nonoperatively managed patients who died #30 days of admission. The median time from hospital admission to intervention among the 29 operative patients was <1 day (range, 0-11 days). The longest delay (11 days to intervention) was in a patient with initially minimally symptomatic type B disease with a proximal extension into the base of his left carotid and who had onset of lower extremity ischemia, which was managed by endovascular fenestration. Another patient had a 7-day interval from admission to surgical management because he had had a prior root repair but required reintervention owing to extension of his dissection, ultimately doing well despite the delay. A third patient had a 5-day delay from admission to intervention because of evaluation for concurrent, symptomatic left main coronary artery disease and did not survive the combined coronary artery bypass and aortic repair.
Of the 30 surviving patients, 24 (80%) were discharged on antiplatelet therapy, and nine (30%) were given anticoagulation. Eight of the nine patients discharged on warfarin anticoagulation were receiving it for mechanical valves and one for atrial fibrillation.
Outcomes are described in Table IV . There were eight inpatient deaths (21% of 38), including two associated with CVA, and eight deaths (21% of 30) during the follow up period, all >30 days after admission. One patient arrived in shock and died before operative intervention. Five patients died during the operation or immediately afterward in the intensive care unit due to extensive blood loss, uncorrectable acidosis, or ventricular failure. Two patients had withdrawal of care without any attempt at aortic intervention after decompressive craniotomies for massive strokes, described above.
Of the 30 patients surviving to discharge, 22 (73%) had at least one subsequent contrast-enhanced CT for follow-up after the initial diagnostic CT and constitute the CTF group. The remaining eight surviving patients (27%) lacked appropriate follow-up imaging and constitute the LCTF group. At a median CT follow-up of 14.5 months, a minority (6 of 22) of lesions had resolved (Fig 2) , but the only postdischarge CVA was in a posterior circulation distribution and thus did not appear to be associated with that patient's CAEAD. Clinical follow-up was available for 21 of 30 patients (70%) surviving to discharge and continued to a median of 4.1 years (Table IV) .
Eleven patients (29%) with CVA or TIA were identified, including eight that were potentially attributable to the carotid lesion. Criteria for diagnosis of a stroke, defined as CVA or TIA, included cross-sectional CT or magnetic resonance imaging or clinical documentation of consistent symptoms. Attribution of CVA was defined by a carotid lesion with evidence of a new, ipsilateral CVA on diagnostic imaging at the time of onset of symptoms. Two of the lesions associated with CAEAD resulted in death. Eight of these 11 CVAs and TIAs (73%) were evident at presentation, and three (27%; 8% of all CAEAD patients) were diagnosed on postoperative days (PODs) 2, 3, and 23. Of the three strokes that occurred after presentation to our medical center, only the CVA that occurred on POD 3 was attributable to the carotid lesion (appearing ipsilateral to the carotid dissection). The strokes on PODs 2 and 23 affected the posterior circulation and occurred in patients with innominate and right carotid involvement. None of the nine patients with late death were reported to have died of a stroke, but these records are necessarily incomplete, and so no overall CAEAD CVA mortality rate or risk can be determined. Six CVAs were identified in the CTF group during the index admission, and all were ischemic lesions. Four of these were apparent on initial presentation, and two were diagnosed on PODs 2 and 3 by physical examination and confirmed by CT. These two patients both had Bentall procedures without arch debranching. Four of the six CVAs were attributable to CAEAD based on laterality. One CVA was diagnosed clinically and confirmed with CT scan on POD 23 in a patient who had also had a Bentall procedure without debranching. This was the only late CVA reported of the 22 patients with CTF. Five deaths occurred in the CTF group during the available clinical follow-up period, for an overall outpatient mortality rate of 22%. These deaths occurred between 2 months and 11 years. Two of those patients who died had suffered CVAs during their hospitalization, but data regarding the cause of death was not available for most patients. In contrast to the CTF group, the LCTF group consisted of eight patients with CAEAD who did not have followup with contrast-enhanced CT scans after admission. There were five male patients (63%) in the LCTF group with a median age of 60.5 years (range, 29-85 years). All eight (100%) were diagnosed with Stanford type A dissections. The common carotid artery dissections were left sided in five patients (63%), right sided in two (25%), and bilateral in one (13%). The LCTF group appeared less likely to receive operative management, with five (63%) being managed nonoperatively. Three had previously had ascending aortic interventions and had presented for their symptomatic CAEAD lesions but required no intervention for the new dissections. Three patients (38%) underwent open surgery at our institution (Fig 1, D) . Two new CVAs were identified in the LCTF group during the index admission, all diagnosed at presentation. Both of the CVAs of the LCTF group could be attributed to the CAEAD. Survival plots of the overall cohort and in patients with or without CVA are shown Kaplan-Meier survival plots for (A) overall survival with carotid artery extension of aortic dissection (CAEAD) and (B) survival in patients with and without cerebrovascular accident (CVA). *Indicates the point at which the standard error >10% in the group without CVA. y Indicates the point at which the standard error >10% in the group that experienced CVA.
occlusion, artery-to-artery embolization, or thrombosis from progressive stenosis. 8 Early literature on CAEAD focused on its association with type A ADs and relied on ultrasound imaging for diagnosis. A retrospective study from Switzerland in the 1980s performed common carotid ultrasound imaging on 39 of 61 patients being operated on for type A AD during a 25-year period. 1 The mostly male sample was an average age of 56 years. A carotid artery dissection was found in 16 of these 39 patients (41%), of which about half were bilateral and the rest were unilateral, with a right-sided predominance. Neurologic symptoms were described in nine patients; however, only two had CVAs corresponding to the carotid lesions for an attributable stroke incidence of 12.5% (2 of 16 patients) at a mean follow-up of 53 months. No additional follow-up was reported. A second study, by Zielinski et al, 10 prospectively obtained carotid duplex studies on 97 patients previously operated on for type A AD. Fifteen patients (15%) had a dissection in at least one common carotid artery, four (4%) had bilateral lesions, and eleven (11%) had right common carotid dissections. Follow-up included a second ultrasound examination at a mean interval of 21 months (range, 5-50 months). Importantly, no new neurologic events or attributable symptoms were reported in their study, despite persistent carotid dissection in 14 of 15 patients. These studies indicated that CAEAD was not as rare as previously thought and demonstrated that the dissections often persist without late CVA. This supports our study's finding that CAEAD is not rare (8.4% of AD patients). Our study also affirmed that CAEAD can be persistent, with only one resolving before 6 months and some still found on follow-up at 64 months. Although these patients present with early strokes attributable to CAE in 21% of our patients, the risk of stroke at 1 year in this population is low, even without operative repair of the carotid dissection. Nevertheless, patients in our series with CAE of their type A dissections typically present with strokes and have a high mortality rate. A study, performed in 2002, evaluated the ultrasound characteristics of the carotid arteries of CAEAD patients who developed stroke (diagnosed on CT) compared with those who did not. 6 They found a right-sided predominance in lesions, and one patient presented with bilateral carotid involvement. Three of nine CAEAD patients (33%) developed a CVA, with thrombus noted in the false lumen of the common carotid or aortas of these patients alone. The authors then theorized that "thrombus in the residual dissection of the aorta, or subsequent artery-to-artery embolization, may play an important role in the pathogenesis of cerebral infarction." 6 Carotid arteries should therefore be imaged in AD patients to distinguish high-risk factors from more innocuous findings on carotid duplex such as double lumens, changes in flow velocity, and intimal flaps. This would potentially allow for selective intervention in those CAEAD patients with false lumen thrombus. Although we did not see this in our study, such a group might merit more aggressive interventions to mitigate risk of CVA. At least one published study suggests that early repair of the AD improves overall neurologic outcomes, supporting intervention on CAEAD. Tsukube et al 11 studied
the carotid arteries of patients with AD who presented with a Glasgow Coma Score of <11, and 17 of 21 patients (81%) had evidence of carotid artery dissection. The authors noted that those patients who underwent hemi or total arch replacement #5 hours of symptom onset had better neurologic recovery (recovery of consciousness and independence in activities of daily living) than those with delayed repair or medical management.
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We did not see strong evidence to support this advice in our patients with CAEAD and had too few patients with an impaired Glasgow Coma Scores at admission to arrive at a meaningful conclusion. Our time to intervention after admission or diagnosis, for two patients with a delayed CAEAD diagnosis, was also very short, so timing of interventions was usually early, and our study was not powered to detect any differences in time to treatment. The largest and most complete single-institution study to date regarding the management of CAEAD was published in 2013 by Charlton-Ouw et al. 9 In this study of 179 patients with type A AD and adequate imaging, CAEAD was found in 43 patients (24%). They were mostly hypertensive men, with an average age of 55 years. The authors reported that stroke on initial presentation appeared more common in patients with CAEAD (18.6%) than those with only AD (8.1%), but this did not meet the cutoff for significance (P ¼ .051). The difference in the rate of postoperative stroke between patients with CAEAD vs AD only (14.6% vs 10.3%) was not significant (P ¼ .44). Of note, there were also no strokes or carotid interventions in the CAEAD group on follow-up after discharge in their study. Therefore, the need for annual carotid duplex surveillance was questioned. The study also demonstrated that the degree of stenosis and false-lumen patency did not affect rates of stroke.
Our current study appears to be consistent with current published literature regarding average age, gender distribution, and comorbidities in patients with CAEAD. However, most studies found a predominance of rightsided carotid dissections, whereas we found more leftsided lesions. Stroke incidence is difficult to determine and varied depending on diagnostic modality and timing of the studies analyzed. As in prior reports, our study demonstrates that although there is a not insignificant risk of early CVA (diagnosis #72 hours of presentation), there is a low risk of CVA after the initial presentation of CAEAD.
Our data support the management algorithm proposed by Charlton-Ouw et al, 8 which emphasized urgent proximal repair of AD, strict blood pressure (systolic blood pressure <120 mm Hg preoperatively, <135 mm Hg postoperatively) and heart rate (<60 beats/min) control, preoperative or immediate postoperative carotid duplex screening for CAE, and 6 months of antithrombotic therapy for those diagnosed with CAEAD. 9 Because many CAEAD lesions persist but appear to rarely cause CVAs at follow-up, the need for annual surveillance is not supported in the absence of significant intraluminal thrombus.
Many of the limitations of our study are inherent in the nature of this type of inquiry. This was a small, singleinstitution retrospective study that depended on accurate entry of International Classification of Diseases, Ninth Revision codes. Patient accrual in this manner can miss patients and is only as robust as the accuracy of coding.
This study shared many of the same limitations stated by Charlton-Ouw et al: many preoperative scans were obtained at another facility, follow-up was incomplete, and there was a lack of dedicated intracranial cerebrovascular imaging for stroke determination. 9 We also present a relatively heterogeneous patient population, which is reflective of the nature of this condition. But the generalizability, or external validity, of the study is satisfactory because the study did not follow a strict protocol for management and did not exclude patients for clinical characteristics. Future avenues of investigation should include prospective analysis of those diagnosed with CAEAD, a comparison of ultrasound imaging vs CT angiographic imaging of carotid arteries, and attempts at more consistent follow-up of clinical status and imaging. Increasing use of CT imaging preoperatively and for follow-up may improve our understanding of the progression or resolution of these lesions and could better define indications for intensive late carotid surveillance.
CONCLUSIONS
In this study, carotid artery involvement of AD was not rare, was associated almost exclusively with type A ADs, was typically unilateral, most often on the left, and usually persisted at follow-up. Many CAEAD patients presented with CVA but not all were attributable to the CAEAD. CVAs were not common after admission, and there appears to be a low risk of new or subsequent stroke in our limited follow-up with routine antiplatelet and antihypertensive therapy. These patients often present with acute and severe strokes with relatively high early mortality. Further prospective study of patients with carotid dissection in the setting of AD is required to develop optimal treatment strategies. 
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